TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33184166

Group type: EXPERIMENTAL
Intervention: Normal saline injectate (3 x 10 mL aliquots)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham injectates (3 x 10 mL)
Number of subjects: 16
Study: 32383964

Group type: EXPERIMENTAL
Intervention: Delirium trajectories based on symptom severity and duration (measured using CAM-ICU and CAM-ICU-7 scales)
Number of subjects: 531
Study: 35121091

Group type: EXPERIMENTAL
Intervention: Nefopam (80 mg continuous intravenous infusion for 24 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0
Study: 34274002

Group type: EXPERIMENTAL
Intervention: PAU-7S
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: MVPA
Number of subjects: 321
Study: 36241857

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Standard dressing
Number of subjects: 377
Study: 34090959

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 32579403

Group type: EXPERIMENTAL
Intervention: 18F-FDG PET-MR
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fecal biomarkers (calprotectin, lactoferrin, polymorphonuclear leukocyte elastase, S100A12, eosinophil-derived neurotoxin)
Number of subjects: 50
Study: 36273313

Group type: EXPERIMENTAL
Intervention: Couples Coping Enhancement Counseling (CCEC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 70
Study: 32700432

Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency combined with passive stretching (PRF-PS) exercise
Number of subjects: 62

Group type: COMPARATOR
Intervention: Passive stretching (PS) exercise
Number of subjects: 62
Study: 35020487

Group type: EXPERIMENTAL
Intervention: Transumbilical laparoscopic surgery (TULS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Laparoscopic‐assisted surgery
Number of subjects: 80
Study: 32867552

Group type: EXPERIMENTAL
Intervention: Early-start donepezil (donepezil-to-donepezil)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Delayed-start (placebo-to-donepezil)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Early-start donepezil
Number of subjects: 98
Study: 33285280

Group type: EXPERIMENTAL
Intervention: Interpersonal behavior change strategies
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Intrapersonal behavior change strategies
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program adapted for small groups
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: PA monitor
Number of subjects: 308

Group type: COMPARATOR
Intervention: No interpersonal behavior change strategies
Number of subjects: 308

Group type: COMPARATOR
Intervention: No intrapersonal behavior change strategies
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Falls
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 308
Study: 32189314

Group type: EXPERIMENTAL
Intervention: Natural B vitamins (group N)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Synthetic B vitamins (group S)
Number of subjects: 30
Study: 35598597

Group type: EXPERIMENTAL
Intervention: Tanshinone IIA (TSA) at concentrations of 1 μg/mL, 10 μg/mL, 100 μg/mL, and 1 mg/mL plus 5 U/mL of thrombin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5 U/mL of thrombin
Number of subjects: 0
Study: 36354237

Group type: EXPERIMENTAL
Intervention: Posisep
Number of subjects: 2

Group type: COMPARATOR
Intervention: PureRegen Gel (PRG)
Number of subjects: 2
Study: 33301785

Group type: EXPERIMENTAL
Intervention: Atropine/Propofol
Number of subjects: 173

Group type: COMPARATOR
Intervention: Atropine/Atracurium/Sufentanil
Number of subjects: 173
Study: 32708973

Group type: EXPERIMENTAL
Intervention: Iron-rich diet (iron intake >20 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ferrous sulfate (FS) supplementation (105 mg/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Iron-rich diet
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ferrous sulfate (FS) supplementation
Number of subjects: 22
Study: 33583683

Group type: EXPERIMENTAL
Intervention: FLASH curriculum (n = 10 schools)
Number of subjects: 1597

Group type: COMPARATOR
Intervention: Knowledge-based sexual health curriculum (n = 10 schools)
Number of subjects: 1597
Study: 35164846

Group type: EXPERIMENTAL
Intervention: Sunset Without AIDS intervention group
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 450
Study: 33124968

Group type: EXPERIMENTAL
Intervention: Multilayer silicone foam dressings applied to the sacrum and coccyx (n = 300)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard care recommended by Japanese guidelines (control; n = 300)
Number of subjects: 600
Study: 33433597

Group type: EXPERIMENTAL
Intervention: Salt nicotine formulation (benzoic acid added)
Number of subjects: 119
Study: 32390731

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) training
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-BFR training
Number of subjects: 12
Study: 36098547

Group type: EXPERIMENTAL
Intervention: Incremental technique (Z350XT, 3M)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Bulk-fill technique (Filtek Bulk Fill, 3M)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Bulk-fill technique (Sonic Fill, Kerr)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Bulk-fill technique (Opus Bulk Fill, FGM)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 47
Study: 33082202

Group type: EXPERIMENTAL
Intervention: Single negative HPV test
Number of subjects: 5537
Study: 32438611

Group type: EXPERIMENTAL
Intervention: Sedentary behavior (14.93 hours per day, SD = 1.76)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Time spent on school assignments on weekends
Number of subjects: 480
Study: 36351955

Group type: EXPERIMENTAL
Intervention: Gradient-based optimization method for determining expression patterns of functional channels in terms of whole‐cell ionic conductance (Gx)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized Gxs of 4‐6 major ionic currents
Number of subjects: 0
Study: 32357362

Group type: EXPERIMENTAL
Intervention: Topical timolol maleate (TTM) 0.5% solution for 12 months
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Topical timolol maleate (TTM) 0.5% solution
Number of subjects: 42

Group type: COMPARATOR
Intervention: Watchful waiting (control group)
Number of subjects: 42
Study: 33486990

Group type: EXPERIMENTAL
Intervention: High TRAP exposure (30,000 particles/cm3 and 826 ng/m3)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Medium TRAP exposure (11,000 particles/cm3 and 409 ng/m3)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Low TRAP exposure (2,500 particles/cm3 and 149 ng/m3)
Number of subjects: 77
Study: 34670456

Group type: EXPERIMENTAL
Intervention: Slow Music Group (SMG)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fast Music Group (FMG)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 45
Study: 35621366

Group type: EXPERIMENTAL
Intervention: 12-week multicomponent exercise intervention based on the integration of the Health Belief Model (HBM) and the Theory of Planned Behaviour (TPB)
Number of subjects: 0
Study: 32463281

Group type: EXPERIMENTAL
Intervention: Active cannabis (5.2% THC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 9
Study: 32267471

Group type: EXPERIMENTAL
Intervention: Risankizumab 150 mg, subcutaneously at weeks 0 and 4
Number of subjects: 507

Group type: COMPARATOR
Intervention: Risankizumab
Number of subjects: 507

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 507
Study: 36162893

Group type: EXPERIMENTAL
Intervention: 1-visit root canal treatment with 2% chlorhexidine (CHX) as final irrigant
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2-visit root canal treatment with calcium hydroxide (CH) dressings
Number of subjects: 100
Study: 32868661

Group type: EXPERIMENTAL
Intervention: Smartphone-based cardiac rehabilitation program (S-CRP)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 206
Study: 36029687

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Unfractionated Heparin
Number of subjects: 534
Study: 34686402

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) distraction during FNA breast biopsy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard protocol without anesthetic during FNA breast biopsy
Number of subjects: 60
Study: 33028480

Group type: EXPERIMENTAL
Intervention: MAP + Treatment as Usual (TAU)
Number of subjects: 65

Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 65
Study: 35390727

Group type: EXPERIMENTAL
Intervention: Recommended protein (RP + T)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: High protein (HP + T)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Observational control (CON)
Number of subjects: 136
Study: 33907936

Group type: EXPERIMENTAL
Intervention: One-implant group (n = 23)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Two-implant group (n = 24)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 47
Study: 32211907

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI) 2 mg (0.05 mL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection (IAI)
Number of subjects: 30
Study: 35700932

Group type: EXPERIMENTAL
Intervention: Clinician perception of patient goals
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Older patients
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Patients with stable goals
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Recent goals-of-care discussion
Number of subjects: 252
Study: 32796329

Group type: EXPERIMENTAL
Intervention: Modified Buried Vertical Mattress Suture (MBVMS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Buried Intradermal Suture (BIS)
Number of subjects: 20
Study: 35488808

Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard Group (SG)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG) with initial severe mental fatigue (MFF)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard Group (SG) with initial severe mental fatigue (MFF)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG) with initial poor motivation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard Group (SG) with initial poor motivation
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Art Therapy Group (ATG) with chemotherapy
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard Group (SG) with chemotherapy
Number of subjects: 320
Study: 32809161

Group type: EXPERIMENTAL
Intervention: Harmonic instruments
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional hemostatic instruments
Number of subjects: 48
Study: 35655233

Group type: EXPERIMENTAL
Intervention: Multifaceted non-surgical intervention (footwear, foot orthoses, foot exercises, advice, and self-management)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Advice and self-management alone
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Multifaceted non-surgical intervention
Number of subjects: 28
Study: 32694318

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Number of subjects: 0
Study: 36442482

Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic target <40th percentile)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 124
Study: 33834643

Group type: EXPERIMENTAL
Intervention: Desmopressin plus anticholinergic (propiverine 5 mg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Desmopressin (monotherapy)
Number of subjects: 99
Study: 32019343

Group type: EXPERIMENTAL
Intervention: Stent-only
Number of subjects: 575

Group type: COMPARATOR
Intervention: Balloon-stent
Number of subjects: 575
Study: 35870327

Group type: EXPERIMENTAL
Intervention: Parent-based treatment
Number of subjects: 96
Study: 33492277

Group type: EXPERIMENTAL
Intervention: Desmotech Training (DT) group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Free Weight Training (WT) group
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 48
Study: 33388227

Group type: EXPERIMENTAL
Intervention: Unilateral vocal fold paralysis group (n=4)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Unilateral cricoarytenoid joint dislocation group (n=4)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal group (n=2)
Number of subjects: 10
Study: 34301613

Group type: EXPERIMENTAL
Intervention: brolucizumab 6 mg
Number of subjects: 69

Group type: COMPARATOR
Intervention: aflibercept 2 mg
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: brolucizumab
Number of subjects: 69

Group type: COMPARATOR
Intervention: aflibercept
Number of subjects: 69
Study: 33187542

Group type: EXPERIMENTAL
Intervention: Smartphone-assisted problem-solving therapy
Number of subjects: 0
Study: 33724637

Group type: EXPERIMENTAL
Intervention: ocrelizumab (OCR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: interferon
Number of subjects: 0
Study: 33308807

Group type: EXPERIMENTAL
Intervention: Pleasant core affect (pleasant pictures)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Unpleasant core affect (unpleasant pictures)
Number of subjects: 31
Study: 35604678

Group type: EXPERIMENTAL
Intervention: Screen media reduction intervention (≤3 hours per week for 2 weeks)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (usual screen media use)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Screen media reduction intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study: 34266506

Group type: EXPERIMENTAL
Intervention: Infant-formula-based complementary feeding pattern (CFP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Breastmilk-based complementary feeding pattern (CFP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Infant-formula-based CFP with high-Fe or mixed PBF
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low-Fe PBF
Number of subjects: 24
Study: 33941140

Group type: EXPERIMENTAL
Intervention: Endoscopic urethrotomy
Number of subjects: 222

Group type: COMPARATOR
Intervention: Open urethroplasty
Number of subjects: 222
Study: 33059084

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation of quadriceps
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment (Control)
Number of subjects: 104
Study: 36113889

Group type: COMPARATOR
Intervention: Education incentive
Number of subjects: 4389

Group type: COMPARATOR
Intervention: Raffle and education incentive
Number of subjects: 4389

Group type: COMPARATOR
Intervention: Raffle incentive
Number of subjects: 4389
Study: 34472929

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation (MM)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Mindfulness Meditation (MM), Cognitive Therapy (CT), Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 57
Study: 34031547

Group type: EXPERIMENTAL
Intervention: Wearing a high‐efficiency particulate‐filtering respirator (PFR) for 48 hours
Number of subjects: 26
Study: 34092640

Group type: EXPERIMENTAL
Intervention: Active laser photobiomodulation (904 nm, 60 mW/diode, 50 Hz) for 33 s to each of 21 points at the cranium and intra-orally, on one, two or three times/week for 4 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham photobiomodulation (placebo)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Active laser photobiomodulation
Number of subjects: 22
Study: 34237764

Group type: EXPERIMENTAL
Intervention: Educational video on pain management
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual discharge pain medication instructions
Number of subjects: 48
Study: 34250918

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Mechanical debridement alone (Control)
Number of subjects: 49
Study: 33396551

Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (Mediterranean diet, exercise, vitamin D)
Number of subjects: 227
Study: 35012708

Group type: EXPERIMENTAL
Intervention: ESS plus medical therapy
Number of subjects: 238

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 238
Study: 33032927

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 27
Study: 35912517

Group type: EXPERIMENTAL
Intervention: Active 10 Hz rTMS (n = 27)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sham rTMS (n = 28)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Active 10 Hz rTMS
Number of subjects: 55
Study: 33794080

Group type: EXPERIMENTAL
Intervention: Avocado/Soy Unsaponifiables (ASU) for three months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Avocado/Soy Unsaponifiables (ASU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35065931

Group type: EXPERIMENTAL
Intervention: Higher levels of carbon monoxide (CO) exposure
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Highest quartile of PM2.5 exposure (≥ 129.9 and ≤ 2100 μg/m3)
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Exposure to black carbon (BC)
Number of subjects: 799
Study: 35227342

Group type: EXPERIMENTAL
Intervention: Resilience Training (RT), n = 54
Number of subjects: 107

Group type: COMPARATOR
Intervention: Waitlist control, n = 53
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Resilience Training (RT)
Number of subjects: 107
Study: 33982949

Group type: EXPERIMENTAL
Intervention: Parechovirus infection
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Parechovirus and enterovirus co-infection
Number of subjects: 220

Group type: COMPARATOR
Intervention: Anellovirus infection
Number of subjects: 220
Study: 33915843

Group type: EXPERIMENTAL
Intervention: Pilates training (2 times per week for 3 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no Pilates training)
Number of subjects: 50
Study: 33849205

Group type: EXPERIMENTAL
Intervention: Progressive relaxation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study: 35258487

Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulator (VRS)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Box-Trainer (BT)
Number of subjects: 77
Study: 33211109

Group type: EXPERIMENTAL
Intervention: Long-term current low-dose aspirin use
Number of subjects: 4710504

Group type: EXPERIMENTAL
Intervention: Episodic low-dose aspirin use
Number of subjects: 4710504

Group type: EXPERIMENTAL
Intervention: Long-term current low-dose aspirin use (subcohort aged 40-59 years)
Number of subjects: 4710504

Group type: EXPERIMENTAL
Intervention: Episodic low-dose aspirin use (subcohort aged 40-59 years)
Number of subjects: 4710504

Group type: COMPARATOR
Intervention: No low-dose aspirin use (control group)
Number of subjects: 4710504
Study: 34656303

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg) and elemental zinc (30 mg) daily for 6 months
Number of subjects: 1470

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1470
Study: 33688713

Group type: EXPERIMENTAL
Intervention: Subgingival reinstrumentation with enamel matrix derivative (EMD)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Subgingival reinstrumentation without enamel matrix derivative (EMD)
Number of subjects: 13
Study: 33128496

Group type: EXPERIMENTAL
Intervention: Skin care regimens containing β‐glucan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 20
Study: 32448931

Group type: EXPERIMENTAL
Intervention: Disaster Worker Resiliency Training Program (DWRT) workshop (n=78)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Waitlist control (n=89)
Number of subjects: 167
Study: 32467559

Group type: EXPERIMENTAL
Intervention: Immediate-release tacrolimus (0.2 mg/kg/day)
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.2 mg/kg/day)
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.3 mg/kg/day)
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Prolonged-release tacrolimus (0.2 mg/kg/day) plus basiliximab
Number of subjects: 1198
Study: 35675611

Group type: EXPERIMENTAL
Intervention: Same-day cervical preparation with osmotic dilators plus buccal misoprostol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overnight osmotic dilators alone
Number of subjects: 0
Study: 33763839

Group type: EXPERIMENTAL
Intervention: AChEI + CS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CS
Number of subjects: 40

Group type: COMPARATOR
Intervention: AChEI
Number of subjects: 40
Study: 32734638

Group type: EXPERIMENTAL
Intervention: Surgiflo® applied at the end of surgery over the whole operative field including the line of airway anastomosis
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no Surgiflo®)
Number of subjects: 55
Study: 35349835

Group type: EXPERIMENTAL
Intervention: JianPiYiFei II granules
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study: 33431358

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) with combination cisplatin (50 mg/m2) plus doxorubicin (15 mg/m2)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) with intense single-agent cisplatin (100 mg/m2)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 16